| WKN: | A1JP9Y |
| ISIN: | DK0060336014 |
| Land: | Dänemark |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Novonesis-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 24. Oktober 2025 Info.
| GD 20 | GD 38 | GD 50 | GD 100 | GD 200 | |
|---|---|---|---|---|---|
| Novonesis | |||||
| TecDax | |||||
| MDax | |||||
| Dax | |||||
| BCDI Deutschland | |||||
| BCDI | |||||
| BCDI USA | |||||
| Euro Stoxx 50 | |||||
| Dow Jones | |||||
| Nasdaq 100 | |||||
| S&P 500 |
| GD 20 | GD 38 | GD 50 | GD 100 | GD 200 | |
|---|---|---|---|---|---|
| Novonesis | |||||
| Abbvie | |||||
| Amgen | |||||
| Bio-Techne | |||||
| Biogen | |||||
| Eurofins Scientific | |||||
| Genmab | |||||
| Gilead Sciences | |||||
| IDEXX Laboratories | |||||
| Moderna | |||||
| Regeneron Pharmaceuticals | |||||
| Sartorius Stedim Biotech | |||||
| Swedish Orphan Biovi | |||||
| UCB |